| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |